Beroe Inc. analyst T.G. Prasanna discusses agentic AI for clinical research and how it must be evaluated as a regulated operating cost transformation, with platform, orchestration, compliance, validation, and oversight costs modeled together.
- Why Life Science Tech Pilots Fail After The Demo — And How To Avoid It
- Inside Versiti's Data Strategy: Building AI-Ready Research Systems
- How Versiti Turns Data Into A Lifeline For Rare Blood Patients
- What Is Shadow AI, And How Does It Impact Clinical Trial Tech?
- Will AI And Agile Project Management Help Advance RBM?
- Building A Clinical Trial Tech Stack That Actually Works
- The Integration Dilemma: Who Decides Which Tech Stack Wins?
- Why Clinical Trial Sites Are Drowning In Tech Chaos
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Fast, Focused Medical Data Review: Use Cases By A Medical Monitor
See how the right data visualization tool can help medical monitors tailor and improve their data review processes and enhance their ability to identify safety signals both quickly and surely.
-
How Heron Therapeutics Sped Up Database Creation
Electronic data capture (EDC) is straightforward, in theory. However, not every EDC is purpose-designed for ease of use by study teams, and some are easier to use and more intuitive than others.
-
The Stakeholder Benefits Of EHR eSource In Clinical Trials
Discover the transformative power of EHR eSource integration through the eyes of a clinical research coordinator and project director in an adaptive platform trial.
-
Harnessing The Power Of eCOA Technology
Get an overview of this COA-focused panel at the C3 Summit in London where industry experts and leaders discussed challenges, opportunities, and strategies in clinical trial diversity, centricity, and outcome assessments.
-
The Catch-22 Of eConsent: A Missed Opportunity For Improved Trials
Drawing on evidence from scientific literature, we examine the pitfalls that have hindered its success and propose actionable solutions to unlock its true value in clinical research.
-
The Strategic Case For RTSM in Phase 1 Trials
Phase 1 trials demand precision and speed. RTSM delivers real-time control over enrollment, dosing, and supply, reducing risk and enabling adaptive strategies that keep timelines on track.
-
Considerations For Implementing The Best eCOAs In Your Trial Design
Dive into considerations when deciding on the best COAs to implement as well as best practices when developing your eCOA strategy in this blog.
-
Flatiron Prospective Evidence Generation
Explore prospective evidence generation and pragmatic approaches that can help you address staffing challenges and the issue of complexity that is driving up the failure rate of clinical studies.
-
The Transformative Role Of Digital Health Technologies
Digital health technologies are transforming clinical trials through decentralization, improved data, and patient-centric approaches, driving efficiency and accessibility.
-
Guide: How Connected Devices Improve Clinical Trial Data
Gain an overview of how and why connected devices provide sponsors and CROs with better clinical trial data, and offer patients much better trial experiences!
- Designing eCOA Technology Patients Can Actually Use
- Clinical Trial Technology Doesn't Fail – It Fails At The Handoff
- Inside Versiti's Data Strategy: Building AI-Ready Research Systems
- How Versiti Turns Data Into A Lifeline For Rare Blood Patients
- Building A Clinical Trial Tech Stack That Actually Works
RECENT NEWSLETTERS
- 07.16.26 -- Why Clinical Trial Sites Are Drowning In Tech Chaos
- 07.09.26 -- AI Governance, Real-Time Trials, And Hidden Risks to Watch
- 07.03.26 -- Best Of June: AI, Data, And What's Fixing Trial Execution
- 07.02.26 -- How AI And Real-Time Tech Are Changing Trial Execution
- 06.25.26 -- How AI, Data, And Workflows Are Fixing Trial Execution